ATE338751T1 - Benzimidazolderivate mit vitronectinrezeptor- antagonistischer wirkung - Google Patents
Benzimidazolderivate mit vitronectinrezeptor- antagonistischer wirkungInfo
- Publication number
- ATE338751T1 ATE338751T1 AT99962691T AT99962691T ATE338751T1 AT E338751 T1 ATE338751 T1 AT E338751T1 AT 99962691 T AT99962691 T AT 99962691T AT 99962691 T AT99962691 T AT 99962691T AT E338751 T1 ATE338751 T1 AT E338751T1
- Authority
- AT
- Austria
- Prior art keywords
- benzimidazole derivatives
- antagonistic effect
- receptor antagonistic
- vitronectin receptor
- vitronectin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20161198A | 1998-11-30 | 1998-11-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE338751T1 true ATE338751T1 (de) | 2006-09-15 |
Family
ID=22746536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99962691T ATE338751T1 (de) | 1998-11-30 | 1999-11-29 | Benzimidazolderivate mit vitronectinrezeptor- antagonistischer wirkung |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1135374B9 (de) |
| JP (1) | JP4480117B2 (de) |
| CN (1) | CN1161340C (de) |
| AR (1) | AR021427A1 (de) |
| AT (1) | ATE338751T1 (de) |
| AU (1) | AU1908400A (de) |
| CA (1) | CA2353063C (de) |
| CO (1) | CO5140112A1 (de) |
| DE (1) | DE69933135T2 (de) |
| ES (1) | ES2273517T3 (de) |
| PE (1) | PE20001427A1 (de) |
| WO (1) | WO2000032578A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010112408A (ko) * | 1999-04-07 | 2001-12-20 | 모리타 다카카즈 | Ｎ-치환되고-Ｎ'-치환된 우레아 유도체 및 ＴＮＦ-α 생성억제제로서의 그의 용도 |
| CA2373892A1 (en) * | 1999-05-17 | 2000-11-23 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| FR2809396B1 (fr) | 2000-05-24 | 2005-10-14 | Centre Nat Rech Scient | Nouvelles molecules possedant une activite calcimimetique et leur mode de preparation |
| US6562807B2 (en) | 2000-06-23 | 2003-05-13 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| EP2527430B1 (de) | 2007-06-07 | 2014-12-31 | Novozymes A/S | Verfahren zur Herstellung eines Produkts auf Teigbasis |
| US10390538B2 (en) | 2010-07-21 | 2019-08-27 | Novozymes A/S | Process for preparing a baked product with anti-staling amylase and peptidase |
| US9951027B2 (en) | 2014-02-11 | 2018-04-24 | Bayer Pharma Aktiengesellschaft | Benzimidazol-2-amines as MIDH1 inhibitors |
| PE20170143A1 (es) | 2014-02-11 | 2017-03-19 | Bayer Pharma AG | Benzimidazol-2-aminas como inhibidores de midh1 |
| CN104694290A (zh) * | 2014-05-07 | 2015-06-10 | 宁波职业技术学院 | 一种洗脚皂 |
| EP3209660B1 (de) | 2014-10-23 | 2020-06-17 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | 1-cyclohexyl-2-phenylaminobenzimidazole als midh1-inhibitoren zur behandlung von tumoren |
| JP6783756B2 (ja) | 2014-10-23 | 2020-11-11 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | ｍＩＤＨ１阻害剤としてのベンゾイミダゾール−２−アミン |
| US10370339B2 (en) | 2015-06-08 | 2019-08-06 | Bayer Pharma Aktiengesellschaft | N-Methylbenzimidazoles as mIDH1 inhibitors |
| JP6824954B2 (ja) | 2015-07-16 | 2021-02-03 | ドイチェス クレープスフォルシュングスツェントルム シュティフトゥング デス エッフェントリッヒェン レヒツ | ｍＩＤＨ１阻害剤としての５−ヒドロキシアルキルベンズイミダゾール |
| TW202146416A (zh) | 2019-12-11 | 2021-12-16 | 德商拜耳廠股份有限公司 | 吡唑并三𠯤 |
| WO2021176045A1 (en) | 2020-03-06 | 2021-09-10 | Bayer Aktiengesellschaft | Imidazotriazines acting on cancer via inhibition of cdk12 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5741796A (en) * | 1994-05-27 | 1998-04-21 | Merck & Co., Inc. | Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption |
| JPH10504808A (ja) * | 1994-06-29 | 1998-05-12 | スミスクライン・ビーチャム・コーポレイション | ビトロネクチン受容体拮抗物質 |
-
1999
- 1999-09-29 CN CNB998158429A patent/CN1161340C/zh not_active Expired - Fee Related
- 1999-11-29 DE DE69933135T patent/DE69933135T2/de not_active Expired - Lifetime
- 1999-11-29 CA CA002353063A patent/CA2353063C/en not_active Expired - Fee Related
- 1999-11-29 EP EP99962691A patent/EP1135374B9/de not_active Expired - Lifetime
- 1999-11-29 WO PCT/US1999/026023 patent/WO2000032578A1/en active IP Right Grant
- 1999-11-29 AT AT99962691T patent/ATE338751T1/de not_active IP Right Cessation
- 1999-11-29 AR ARP990106061A patent/AR021427A1/es unknown
- 1999-11-29 ES ES99962691T patent/ES2273517T3/es not_active Expired - Lifetime
- 1999-11-29 JP JP2000585220A patent/JP4480117B2/ja not_active Expired - Lifetime
- 1999-11-29 AU AU19084/00A patent/AU1908400A/en not_active Abandoned
- 1999-11-30 PE PE1999001198A patent/PE20001427A1/es not_active Application Discontinuation
- 1999-11-30 CO CO99075257A patent/CO5140112A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1135374B9 (de) | 2007-02-21 |
| CN1161340C (zh) | 2004-08-11 |
| DE69933135D1 (de) | 2006-10-19 |
| JP4480117B2 (ja) | 2010-06-16 |
| ES2273517T3 (es) | 2007-05-01 |
| CN1333755A (zh) | 2002-01-30 |
| AU1908400A (en) | 2000-06-19 |
| CA2353063C (en) | 2009-06-16 |
| EP1135374B1 (de) | 2006-09-06 |
| AR021427A1 (es) | 2002-07-17 |
| WO2000032578A1 (en) | 2000-06-08 |
| WO2000032578A8 (en) | 2002-02-07 |
| CA2353063A1 (en) | 2000-06-08 |
| DE69933135T2 (de) | 2007-08-09 |
| PE20001427A1 (es) | 2000-12-18 |
| CO5140112A1 (es) | 2002-03-22 |
| JP2002531441A (ja) | 2002-09-24 |
| EP1135374A1 (de) | 2001-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE264317T1 (de) | Benzimidazol-derivate mit antihistaminischer wirkung | |
| ATE246700T1 (de) | Benzimidazolderivate | |
| DE60219513D1 (de) | Sauerstoffbefeuerter zirkulierender wirbelschichtdampferzeuger | |
| IS5706A (is) | Adenosín A3 viðtakastillar | |
| EE200300244A (et) | 3-aroüülindooli derivaadid ja nende kasutamine CB2-retseptorite agonistidena | |
| DE60026169D1 (de) | Selektive neurokinin-antagonisten | |
| MA26816A1 (fr) | Derives d'amino-triazolopyridine | |
| ATE456559T1 (de) | Piperazinderivate mit ccr1-rezeptor- antagonistischer wirkung | |
| ATE280157T1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| ATE338751T1 (de) | Benzimidazolderivate mit vitronectinrezeptor- antagonistischer wirkung | |
| DK1202953T3 (da) | Substituerede 2-dialkylaminoalkylbiphenylderivater | |
| IT1314191B1 (it) | Derivati isossazolcarbossamidici | |
| NO20004503L (no) | Vitronectin-reseptor-antagonister | |
| NO20013997D0 (no) | Reseptoranalyse | |
| EE200200204A (et) | Asendatud bensimidasooli preparaat | |
| ATE277043T1 (de) | Vitronectin rezeptor antagonist | |
| DE60012062D1 (de) | Fluorierte Triazinderivate | |
| FI990800A0 (fi) | Verkkoelementti | |
| TR200002831A3 (tr) | Kinolin-4-Il türevleri I | |
| NO20021113D0 (no) | Vitronectin-reseptor-antagonister | |
| NO20015237L (no) | Integrinreseptor-antagonister | |
| NO20021295L (no) | Nikotinsyreacetylcholin-reseptor | |
| NO20010620D0 (no) | Vitronektinreseptor-antagonister | |
| NO20011779L (no) | Ureidopiperidinderivater som selektive humane NK3 reseptor antagonister | |
| ITMI991704A0 (it) | Derivati tienopirancarbossamidici |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |